Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-005618
NCT ID: NCT03766347
Sponsor Protocol Number: 17-005618
About this study
The purpose of this study is to collect information on the natural history of neuromyelitis optica spectrum disorder (NMOSD) in pediatric AQP4-IgG seropositive patients in the Mayo Clinic neuromyelitis optica spectrum disorder (NMOSD) Pediatric Repository.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- NMOSD/AQP4-IgG positive at time of enrollment, or historically positive sample tested on a reliable assay [ex. cell based assay (CBA), or fluorescence-activated cell sorting (FACS)].
- Diagnosis of NMOSD
- Male and female children
- Age between 2-17 years at time of enrollment
- Ability to give consent/assent (by patient or caregiver) as appropriate per IRB guidelines
- Ability and willingness to complete the study
Exclusion Criteria:
- Inability to provide informed consent
- Inability to complete required forms via phone, mail or email.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Sean Pittock, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available